All Things Considered for January 2, 2013
Jan 2, 2013 — At its height, American tennis consistently fielded the world's top male players. Now that American dominance is gone, so too are many of the top U.S. men's tournaments. They're moving overseas, snapped up by groups offering more lucrative payouts in a sport enjoying huge global appeal.
Jan 2, 2013 — The aircraft is intended to serve the Air Force, the Navy and the Marines for decades to come. But delays and cost overruns keep pushing up the price. Lockheed Martin, the manufacturer, says the cost will come down as production ramps up.
Jan 2, 2013 — The success of Kalydeco, a drug to treat cystic fibrosis, has been decades in the making — since the discovery of the gene associated with the disease. The time from gene discovery to successful drug may be shortening, but there are only a handful of drugs like Kalydeco on the market.
Jan 2, 2013 — In Silicon Valley and around the world there are thousands of folks toiling away on new technologies, convinced that the thing they are building will transform the way we live. NPR's Steve Henn introduces us to five techies whose research and work he'll be keeping a close eye on in the coming year.